Table 1 Characteristics of preterm patients with a history of retinopathy of prematurity with treatment, spontaneously regressed, and full-term healthy controls.
tROP patients (n = 38) | srROP patients (n = 40) | Healthy controls (n = 43) | p value | |
|---|---|---|---|---|
Variables | Mean ± SD | Mean ± SD | Mean ± SD | |
Gender, male/female | 18/20 | 23/17 | 24/19 | 0.6305a |
Examination age, years | 8 ± 2 | 7 ± 2 | 8 ± 3 | 0.1061b |
Gestational age, weeks | 26.00 ± 2.4 | 26.98 ± 2.2 | 0.0105c | |
Birth weight, g | 867.82 ± 333.5 | 965.8 ± 228.8 | 0.0232c | |
Spherical equivalent, diopters | − 3.59 ± 2.73 | 0.31 ± 1.91 | − 1.87 ± 3.15 | < 0.0001b |
Last BCVA, logMAR | 0.25 ± 0.20 | 0.13 ± 0.15 | 0.03 ± 0.06 | < 0.0001b |
Axial length, mm | 22.57 ± 1.47 | 22.33 ± 1.04 | 24.06 ± 1.89 | 0.0002b |
ROP stage | ||||
Stage 1 (n, %) | 0, 0 | 10, 25 | ||
Stage 2 (n, %) | 0, 0 | 23, 58 | ||
Stage 3 (n, %) | 38, 100 | 7, 18 | ||
Treatment | ||||
Laser | 38 (100%) | 0 |